Daubert v. Merrell Dow Pharmaceuticals

(redirected from 113 S Ct 2786 1993)
Also found in: Wikipedia.

A lawsuit by brought by J. Daubert, who was born with limb-reduction defects, alleging that the cause of his disability was Bendectin, produced by Merrell Dow Pharmaceuticals

Medical browser ?

▲
011A cell
1 diffusibility
1 H
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)
1,1'-dioctadecyl-3,3,3 ,3 -tetramethylindocarocyanine perchlorate
1,25-dihydroxyergocalciferol
1,25-dihydroxyvitamin D
1,25-dihydroxyvitamin D3
1,2-dibromoethane
1,3-bisphosphoglycerate
1,3-butanediol
1,3-diphosphoglycerate
1,3-P2Gri
1,4 butanediol
1,4-alpha-d-glucan 6-alpha-d-glucosyltransferase
1,4-alpha-d-glucan-branching enzyme
1,4-alpha-glucan branching enzyme
1,4-benzoquinone
1,4-bis(5-phenyloxazol-2-yl)benzene
1,5 anhydroglucitol
1,5-vinyl-2-thioxazolidone
1,6-glucosidase
100% displaced fracture
10-Sep
111In
113 S Ct 2786 1993
113Sn
11-beta-hydroxysteroid dehydrogenase
11C
11-cis-retinal
11-cis-retinol
11-dehydrocorticosterone
11-deoxycortisol
11-desoxycorticosterone
11-hydroxycorticosteroids
11-hydroxyetiocholanolone
11-hydroxylase deficiency
11-oxycorticoid
11-oxycorticoids
11-Sep
12C
12-O-tetradecanoylphorbol 13-acetate
12-Sep
12-step program
131 I
131I
131I uptake test
132 I
132I
133Xe
13C
▼

CITE

Site: Follow: Share:

Open / Close